Structure-Based Approach to the Development of Potent and Selective Inhibitors of Dihydrofolate Reductase from Cryptosporidium
- 4 October 2008
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 51 (21) , 6839-6852
Abstract
Cryptosporidiosis is an emerging infectious disease that can be life-threatening in an immune-compromised individual and causes gastrointestinal distress lasting up to 2 weeks in an immune-competent individual. There are few therapeutics available for effectively treating this disease. We have been exploring dihydrofolate reductase (DHFR) as a potential target in Cryptosporidium. On the basis of the structure of the DHFR enzyme from C. hominis, we have developed a novel scaffold that led to the discovery of potent (38 nM) and efficient inhibitors of this enzyme. Recently, we have advanced these inhibitors to the next stage of development. Using the structures of both the protozoal and human enzymes, we have developed inhibitors with nanomolar potency (1.1 nM) against the pathogenic enzyme and high levels (1273-fold) of selectivity over the human enzyme.Keywords
This publication has 21 references indexed in Scilit:
- In pursuit of virtual lead optimization: Pruning ensembles of receptor structures for increased efficiency and accuracy during dockingProteins: Structure, Function, and Bioinformatics, 2009
- In pursuit of virtual lead optimization: The role of the receptor structure and ensembles in accurate dockingProteins: Structure, Function, and Bioinformatics, 2008
- Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta‐analysisBritish Journal of Clinical Pharmacology, 2007
- Synthesis of the Bestmann-Ohira ReagentSynthesis, 2006
- A Novel Ensemble-Based Scoring and Search Algorithm for Protein Redesign and Its Application to Modify the Substrate Specificity of the Gramicidin Synthetase A Phenylalanine Adenylation EnzymeJournal of Computational Biology, 2005
- Expedient Total Syntheses of Rhein and Diacerhein via Fries RearrangementThe Journal of Organic Chemistry, 2004
- Surflex: Fully Automatic Flexible Molecular Docking Using a Molecular Similarity-Based Search EngineJournal of Medicinal Chemistry, 2003
- Atomic Structures of Human Dihydrofolate Reductase Complexed with NADPH and Two Lipophilic Antifolates at 1.09Å and 1.05Å ResolutionJournal of Molecular Biology, 2002
- Dicyclic and Tricyclic Diaminopyrimidine Derivatives as Potent Inhibitors of Cryptosporidium parvum Dihydrofolate Reductase: Structure-Activity and Structure-Selectivity CorrelationsAntimicrobial Agents and Chemotherapy, 2001
- Cryptosporidiosis: An Emerging, Highly Infectious ThreatEmerging Infectious Diseases, 1997